Sandra McBurnett

Sandra McBurnett, MBA, currently serves as the Director of Clinical Supply Chain at Eikon Therapeutics, beginning in February 2024. Previously, Sandra held the title of Associate Director of Clinical Supply Chain Operations at Pfizer following a change due to acquisition, and also worked with Global Blood Therapeutics, where responsibilities included leading a team of five, overseeing packaging and logistics for multiple global programs, and managing vendor relationships. Sandra's extensive experience includes roles at Almac Group, where project leadership involved managing over 20 active studies, and earlier positions at BioNumerik Pharmaceuticals, where coordination of a Phase III oncology trial was a key focus. Sandra began a career in event management, contributing to client satisfaction in hospitality settings before transitioning to clinical project management. Academic qualifications include an MBA from St. Edward's University and a BBA from the University of Texas at San Antonio.